Group 1 - The Shanghai Cooperation Organization (SCO) held its eighth health ministers' meeting in Xi'an, focusing on promoting sustainable health development and sharing a healthy future [1] - SCO member countries agreed to deepen cooperation in emergency medicine, primary health care, digital health, and traditional medicine [1] - Chinese vaccine company Sinovac has established a diverse cooperation system with multiple countries under the SCO framework, covering research, supply, and industrialization [1] Group 2 - Sinovac has supplied over 33 million doses of routine vaccines, including hepatitis A, flu, and varicella vaccines, to SCO member countries [1] - The hepatitis A vaccine from Sinovac is the preferred choice for immunization programs in several SCO countries, with over 10 million doses supplied to Uzbekistan, Kazakhstan, India, and Pakistan [1] - In Uzbekistan, Sinovac's hepatitis A vaccine achieved over 95% market share in the private sector, with a coverage rate exceeding 69% for children in 2024 [1] Group 3 - Sinovac's varicella vaccine received prequalification from the World Health Organization, and it was first supplied to Belarus in late 2023, addressing a shortage of varicella vaccines [1] - Sinovac's flu vaccine was launched in Pakistan in 2024 and quickly became a mainstream brand [2] - Sinovac donated 100,000 doses of inactivated hepatitis A vaccine to Pakistan during severe flooding in 2022, receiving appreciation from local health authorities [2] Group 4 - Sinovac is actively engaged in industrial cooperation with SCO partners, including establishing a vaccine factory in Turkey and building a large automated vaccine cold storage facility in Egypt [2] - The cold storage facility in Egypt is the largest vaccine storage center in Africa, covering an area of 2,800 square meters [2] - Sinovac has developed 12 vaccines over its 24 years of operation, gaining wide recognition globally [2]